US M&A and equity raisings

3,392 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds

Deals dated after 30 September 2026 are still being collected.

Deal size
Custom range

445 deals · US$333bndisclosed · Healthcare · Clear

Columns
US M&A deals and equity raisings
Date Target Vendor Acquirer Type Status Value US$m Sector Advisers
May 2026 Anagram Therapeutics ––StakeAnnounced–Biotech+2 Goodwin (sell-side)
May 2026 Catalyst Pharmaceuticals –Angelini Pharma S.p.A.AcquisitionPending4,100.0Pharma+1 J.P. Morgan (sell-side)Kirkland & Ellis (sell-side)Akerman (sell-side)Centerview Partners (buy-side)BNP Paribas (buy-side)Morgan Stanley (buy-side)Hogan Lovells Cadwalader (buy-side)Gatti Pavesi Bianchi Ludovici (buy-side)
May 2026 CDMO and Cell Solutions businesses of Charles River Laboratories Charles River Laboratories InternationalGI PartnersAsset saleCompleted–Pharma Services+2 Moelis & Company (buy-side)Ropes & Gray (buy-side)
May 2026 Health Elements AI –MedisolvAcquisitionAnnounced–Healthcare Software+1 Gibson Dunn (buy-side)
May 2026 Lilac Software –MedisolvAcquisitionAnnounced–Healthcare Software+2 Gibson Dunn (buy-side)
May 2026 Perfuse Therapeutics –BayerAcquisitionAnnounced300.0Biotech+2 Goodwin (sell-side)
May 2026 Cross Country Healthcare –Knox LaneAcquisitionCompleted437.0Healthcare Staffing BofA Securities (sell-side)Davis Polk (sell-side)MTS Health Partners (buy-side)Kirkland & Ellis (buy-side)
May 2026 Candid Therapeutics –UCBAcquisitionAnnounced2,200.0Biotech+1 LazardCooley (sell-side)
May 2026 Esperion Therapeutics –ARCHIMEDAcquisitionPending1,100.0Pharma+1 Latham & WatkinsCenterview Partners (sell-side)Goodwin (sell-side)Moelis & Company (buy-side)Sidley Austin (buy-side)
May 2026 Vastian –Bregal SagemountStakeAnnounced–Healthcare Software+1 Kirkland & Ellis (sell-side)Baird (sell-side)
May 2026 EqualizeRCM –CarlyleAcquisitionCompleted–Healthcare Services+1 TripleTreeLatham & Watkins (buy-side)
May 2026 Regenity Biosciences –CinvenStakeAnnounced–Medtech+1 Baird (sell-side)
May 2026 LimmaTech Biologics AG –Eli Lilly and CompanyAcquisitionPending780.0Biotech Goodwin (sell-side)Kirkland & Ellis (buy-side)
May 2026 HealthEZ –Horizon Mutual HoldingsAcquisitionCompleted–Healthcare Services+1 TripleTree
May 2026 Replay –LEO PharmaAcquisitionAnnounced50.0Biotech+2 Latham & Watkins (buy-side)
May 2026 SPR Therapeutics –MedtronicAcquisitionAnnounced650.0Medtech Latham & Watkins (sell-side)
May 2026 PathAI –RocheAcquisitionPending750.0Healthcare Software+2 Latham & Watkins (sell-side)Davis Polk (buy-side)
May 2026 Estia Health Bain CapitalStonepeakAcquisitionCompleted–Healthcare Services Gresham (sell-side)Allens (sell-side)Barrenjoey (sell-side)MinterEllison (buy-side)
Apr 2026 vVARDIS Holding AG ––StakeAnnounced–Medtech Sidley Austin (buy-side)
Apr 2026 KalVista Pharmaceuticals –Chiesi GroupAcquisitionCompleted1,900.0Pharma+2 Centerview Partners (sell-side)Kirkland & Ellis (sell-side)Fenwick & West (sell-side)Jefferies (sell-side)Lazard (buy-side)Ropes & Gray (buy-side)
Apr 2026 Shionogi-Apnimed Sleep Science ApnimedShionogi & Co.AcquisitionAnnounced100.0Pharma+1 Goodwin (sell-side)
Apr 2026 Emalex Biosciences –Teva PharmaceuticalsAcquisitionAnnounced700.0Pharma+1 Centerview Partners (sell-side)Bradley Arant Boult Cummings (sell-side)Evercore (buy-side)Faegre Drinker Biddle & Reath (buy-side)
Apr 2026 Naveris –CareDxAcquisitionAnnounced160.0Diagnostics+1 J.P. Morgan (sell-side)Skadden, Arps, Slate, Meagher & Flom (sell-side)Goldman Sachs (buy-side)Fenwick & West (buy-side)
Apr 2026 Ajax Therapeutics –Eli Lilly and CompanyAcquisitionAnnounced2,300.0Biotech+2 Cooley (sell-side)Kirkland & Ellis (sell-side)Ropes & Gray (buy-side)
Apr 2026 XOMA Royalty –Ligand PharmaceuticalsAcquisitionCompleted739.0Specialty finance and leasing+2 Leerink Partners (sell-side)H.C. Wainwright & Co. (sell-side)Gibson Dunn (sell-side)Stifel (buy-side)Citi (buy-side)Paul Hastings (buy-side)Collected Strategies (buy-side)
Apr 2026 Organon & Co. –Sun Pharmaceutical IndustriesAcquisitionAnnounced11,750.0Pharma Morgan Stanley (sell-side)Goldman Sachs (sell-side)Sullivan & Cromwell (sell-side)Cyril Amarchand Mangaldas (sell-side)J.P. Morgan (buy-side)Jefferies (buy-side)White & Case (buy-side)AZB & Partners (buy-side)
Apr 2026 CathWorks –MedtronicAcquisitionAnnounced585.0Medtech+1 Goodwin (sell-side)
Apr 2026 TruBridge –Inventurus Knowledge SolutionsAcquisitionAnnounced–Healthcare Software+1 Solomon Partners (sell-side)Sullivan & Cromwell (sell-side)Maynard Nexsen (sell-side)Cyril Amarchand Mangaldas (sell-side)Willkie Farr & Gallagher (sell-side)J.P. Morgan (buy-side)Citi (buy-side)Katten Muchin Rosenman (buy-side)Shardul Amarchand Mangaldas & Co (buy-side)
Apr 2026 Kashiv BioSciences –Amneal PharmaceuticalsAcquisitionCompleted375.0Biotech+2 J.P. Morgan (sell-side)Holland & Knight (sell-side)Goldman Sachs (buy-side)Richards, Layton & Finger (buy-side)Simpson Thacher & Bartlett (buy-side)Boston Consulting Group (buy-side)
Apr 2026 Bonsai Health –ModMedAcquisitionAnnounced–Healthcare Software+1 Sidley Austin (buy-side)
Apr 2026 Cumberland FDA-approved commercial products and related assets Cumberland PharmaceuticalsNuvo Pharmaceuticals (Ireland) DACAsset salePending100.0Pharma VelocityHealth Securities (sell-side)Baker Donelson (sell-side)Kirkland & Ellis (buy-side)
Apr 2026 Certara Regulatory and Medical Writing business CertaraVeristatAsset saleAnnounced135.0Pharma Services+1 Perella Weinberg Partners (sell-side)Troutman Pepper Locke (sell-side)Guggenheim Securities (buy-side)McDermott Will & Schulte (buy-side)
Apr 2026 Sila Realty Trust –Blue Owl Real Estate Capital LLC affiliatesAcquisitionCompleted2,400.0REITs+1 BofA Securities (sell-side)Hogan Lovells Cadwalader (sell-side)Venable (sell-side)Citi (buy-side)Truist Securities (buy-side)Newmark (buy-side)Kirkland & Ellis (buy-side)Dechert (buy-side)
Apr 2026 Kelonia Therapeutics –Eli Lilly and CompanyAcquisitionAnnounced7,000.0Biotech+2 Goodwin (sell-side)Jefferies (sell-side)Kirkland & Ellis (buy-side)
Apr 2026 Neurona Therapeutics –UCBAcquisitionAnnounced650.0Biotech+2 Centerview Partners (sell-side)Wilson Sonsini Goodrich & Rosati (sell-side)BofA Securities (buy-side)Covington & Burling (buy-side)
Apr 2026 Robocath –StereotaxisAcquisitionAnnounced–Medtech+1 Goodwin (sell-side)
Apr 2026 Avanos Medical –AIPAcquisitionCompleted1,272.0Medtech J.P. Morgan (sell-side)Alston & Bird (sell-side)UBS (sell-side)Joele Frank, Wilkinson Brimmer Katcher (sell-side)Sidley Austin (buy-side)Ropes & Gray (buy-side)Baker Botts (buy-side)Guggenheim Securities (buy-side)
Apr 2026 CrossBridge Bio –Eli Lilly and CompanyAcquisitionAnnounced300.0Biotech+2 Cooley (sell-side)
Apr 2026 Obsidian Therapeutics –Galera TherapeuticsMergerCompleted413.5Biotech+2 Goodwin (sell-side)Sidley Austin (buy-side)Leerink Partners (sell-side)Lucid Capital Markets (buy-side)
Apr 2026 Healthcare Linen Services Group York Private EquityThe Sterling GroupAcquisitionCompleted–Industrial Services+1 BofA Securities (sell-side)KeyBanc Capital Markets (sell-side)Sidley Austin (sell-side)Stephens (buy-side)Latham & Watkins (buy-side)Weil, Gotshal & Manges (buy-side)
Apr 2026 US sales and distribution rights for seven Assertio branded products Assertio HoldingsCosette PharmaceuticalsAsset saleAnnounced–Pharma Gibson Dunn (sell-side)
Apr 2026 OFFOR Health –Havencrest Capital ManagementAcquisitionCompleted–Healthcare Services Cascadia Capital (buy-side)Ziegler (sell-side)Bass, Berry & Sims (buy-side)
Apr 2026 Bentec Medical Greyrock Capital GroupAvista Healthcare PartnersAcquisitionCompleted–Medtech+1 Piper Sandler (sell-side)McGuireWoods (sell-side)Willkie Farr & Gallagher (buy-side)
Apr 2026 Assertio non-Rolvedon assets (Indocin, Sympazan, Sprix, Cambia, Zipsor, Otrexup) Assertio HoldingsCosette PharmaceuticalsAsset saleCompleted35.0Pharma Moelis & Company (sell-side)Gibson Dunn (sell-side)
Apr 2026 MethodOne by Computalogic –QualifactsAsset saleAnnounced–Healthcare Software+1 Orrick (buy-side)
Apr 2026 Worldwide rights to Kenalog Bristol-Myers SquibbSubsidiary of Piramal PharmaAsset saleAnnounced35.0Pharma Goodwin (buy-side)
Apr 2026 Assertio Holdings –Zydus Worldwide DMCCAcquisitionAnnounced166.4Pharma Moelis & Company (sell-side)Gibson Dunn (sell-side)Longacre Square Partners (sell-side)Paul, Weiss (buy-side)
Apr 2026 d2i –ESO SolutionsAcquisitionAnnounced–Healthcare Software+1 Kirkland & Ellis (buy-side)
Apr 2026 Tubulis EQT Life Sciences (LSP 7 fund)Gilead SciencesAcquisitionAnnounced3,150.0Biotech+2 Goodwin (sell-side)J.P. Morgan (sell-side)CMS (sell-side)Centerview Partners (buy-side)Allen & Company (buy-side)Covington & Burling (buy-side)Arnold & Porter (buy-side)Venable (buy-side)
Apr 2026 Soleno Therapeutics –Neurocrine BiosciencesAcquisitionCompleted2,900.0Biotech+2 Centerview Partners (sell-side)Guggenheim Securities (sell-side)Wilson Sonsini Goodrich & Rosati (sell-side)Goodwin (sell-side)Goldman Sachs (buy-side)Cooley (buy-side)

Deals come from SEC filings (merger proxies, tender offers, 8-K announcements and IPO prospectuses), the deal pages and transaction lists of law firms and banks, companies' press releases and the press. How the data is built